CHLOROPTIC Drug Patent Profile
Which patents cover Chloroptic, and when can generic versions of Chloroptic launch?
Chloroptic is a drug marketed by Allergan and is included in three NDAs.
The generic ingredient in CHLOROPTIC is chloramphenicol; prednisolone. There are two drug master file entries for this compound. Additional details are available on the chloramphenicol; prednisolone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CHLOROPTIC?
- What are the global sales for CHLOROPTIC?
- What is Average Wholesale Price for CHLOROPTIC?
Summary for CHLOROPTIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Patent Applications: | 3,216 |
| DailyMed Link: | CHLOROPTIC at DailyMed |
US Patents and Regulatory Information for CHLOROPTIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | CHLOROPTIC | chloramphenicol | SOLUTION/DROPS;OPHTHALMIC | 050091-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Allergan | CHLOROPTIC S.O.P. | chloramphenicol | OINTMENT;OPHTHALMIC | 061187-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Allergan | CHLOROPTIC-P S.O.P. | chloramphenicol; prednisolone | OINTMENT;OPHTHALMIC | 061188-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
